A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with persistent asthma

BACKGROUND: Budesonide and formoterol (BF) Spiromax® is a dry powder inhaler designed to deliver BF with maximum ease of use for patients with asthma or chronic obstructive pulmonary disease. METHODS: A phase 3b, 12-week, multicenter, double-blind, double-dummy, randomized, controlled trial in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Virchow, J. Christian, Rodriguez-Roisin, Roberto, Papi, Alberto, Shah, Tushar P., Gopalan, Gokul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794916/
https://www.ncbi.nlm.nih.gov/pubmed/26987997
http://dx.doi.org/10.1186/s12890-016-0200-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794916/
https://www.ncbi.nlm.nih.gov/pubmed/26987997
http://dx.doi.org/10.1186/s12890-016-0200-x

Ejemplares similares